Upload others
View 2
Download 0
Embed Size (px) 344 x 292 429 x 357 514 x 422 599 x 487
Citation preview
Torrent Pharmaceuticals Ltd Investor Presentation Q1 FY 2012
Investor Call Re Valeant Pharmaceuticals
INVESTOR PRESENTATION NOVEMBER 2019 · INVESTOR PRESENTATION NOVEMBER 2019. Important Notice. 2. This presentation has been prepared by AFT Pharmaceuticals Limited (“AFT”), to
AFT PHARMACEUTICALS - Bioshares...Queenstown, New Zealand Bioshares Presentation July 2018 IMPORTANT NOTICE This presentation has been prepared by AFT Pharmaceuticals Limited (“AFT”),
Investor Presentation May 7, 2013 ISIS PHARMACEUTICALS
Addex Pharmaceuticals Investor Relations Presentation October 2009
Addex Pharmaceuticals Investor Presentation July 2010
Addex Pharmaceuticals Investor Relations Slides January 2010
BAFNA PHARMACEUTICALS LIMITEDbafnapharma.com/pdf/NOTICE-OF-21st-AGM.pdf · BAFNA PHARMACEUTICALS LIMITED CIN ... the shareholders may also send requests to the Company‟s investor
Biostar Nasdaq: BSPM Pharmaceuticals,Inc. Investor Presentation Aug 2014
IOL Chemicals and Pharmaceuticals Limited Investor ... Presentation - IOL_16...2021/02/16 · About IOL Chemicals and Pharmaceuticals Limited Incorporated in 1986, IOLCP is one of
Addex Pharmaceuticals Investor Presentation October 2010
IOL Chemicals and Pharmaceuticals Limited Investor
NPS Pharmaceuticals Investor Slide Deck
TRACON PHARMACEUTICALS Investor Presentation
Inovio Pharmaceuticals 2012 Investor Presentation
ACTELION’S CARDIOVASCULAR PIPELINE INVESTOR WEBCAST · © 2016 Actelion Pharmaceuticals Ltd PULMONARY AND SYSTEMIC CIRCULATION PATHWAYS 4 07 Nov 2016 Investor webcast
GW Pharmaceuticals Investor Presentation
Addex Pharmaceuticals Investor Presentation September 2010
Torrent Pharmaceuticals Ltd Investor Presentation Q2 FY 2012
Addex Pharmaceuticals Investor Presentation February 2010
Investor Day - Alexion Pharmaceuticals, Inc
Symposium Investor Roadshow November 2015 - MGC Pharmaceuticals
Valeant Pharmaceuticals International, Inc./media/Files/V/Valeant-IR/... · 2015-12-09 · Valeant Pharmaceuticals International, Inc. Investor Conference Call October 26, 2015
Investor Day - Genomic Vision › ... › Genomic-Vision-Investor... · Erwan Martin, MBA CFO • Previously with Cytomics Pharmaceuticals (CFO) and Syndex (French audit company)
INVESTOR UPDATEaarti-industries.com/media/investors/presentations/...•Leading manufacturer of Speciality Chemicals & Pharmaceuticals with diversified end-uses in Pharmaceuticals,
IMPRIMIS PHARMACEUTICALS NASDAQ: IMMYfilecache.drivetheweb.com/ir1_imprimis/177/download/IMMY-Investor... · IMPRIMIS PHARMACEUTICALS NASDAQ: IMMY ... actual results could vary materially
AFT PHARMACEUTICALS - ASX · June 2016. 5. ACCELERATING CLINICAL STUDY PROGRAM • 12 studies across the AFT portfolio • 1500+ patients • 7 countries - Australia, Jordan, Mexico,
AFT PHARMACEUTICALS · 2018. 8. 6. · This presentation has been prepared by AFT Pharmaceuticals Limited (“AFT”), to provide a general overview of AFT. It is not prepared for